SU-9902

N/A

Report date: 2023/06/14 09:12:54
NME

Base Information

Drug NameSU-9902
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionVascular endothelial growth factor receptor antagonistsFibroblast growth factor receptors antagonistsProtein-tyrosine kinases inhibitors
TargetsProtein-tyrosine kinasesVascular endothelial growth factor receptorFibroblast growth factor receptors
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSugen LlcThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSugen LlcThe University Of Texas MD Anderson Cancer Center
Active IndicationsN/A
Inactive IndicationsGlioma

Other Information

ATC CodeN/A
Related LinksN/A